LatentLabs

Generative protein design for antibodies, macrocycles and mini-binders

Advanced
Screenshot of LatentLabs, Generative protein design for antibodies, macrocycles and mini-binders

What is LatentLabs?

LatentLabs is an AI simulation generator tool. A beta platform for generative protein design built on the Latent-X family of models. It proposes antibodies, macrocycles and mini-binders against a target, with a public gallery of experimentally validated designs and linked technical reports on arXiv.

Latent Labs is a protein design platform built around Latent-X, a generative model that proposes binding proteins against a chosen target. The company positions the output as lab-ready rather than purely computational: the homepage presents a gallery of binders that have been experimentally tested, spanning antibodies, macrocycles and mini-proteins, each tied to a named target and a measured affinity value. Reported examples range from low picomolar antibodies to micromolar binders, which gives a realistic sense of the spread rather than a single best case. In practice the product is a design workspace. A user starts a design run against a target of interest, and the platform returns candidate binders with output pages that can be opened and inspected individually; several public demo outputs are linked straight from the homepage so the format can be judged before requesting access. Three model lines are referenced (Latent-X1, Latent-X2 and Latent-Y) and each has a technical report on arXiv, which matters for teams who need to evaluate methodology before committing to a vendor. The audience is computational biologists, protein engineers and antibody discovery groups in biotech and pharma, plus academic labs that want generative designs without building a model in house. The emphasis on drug-like properties and lab success rates suggests it is aimed at groups moving toward wet-lab validation, not just in silico exploration. Among alternatives, Latent Labs differentiates on validation transparency and on covering three distinct binder formats in one platform. The trade-off is that access is gated and the public information is thin on limits, quotas and data handling. At the time of writing the site is labeled beta and pricing sits behind an access request, so buyers should expect to talk to the company rather than self-serve.

How do you use LatentLabs?

  1. 1Review the validated design gallery
    Start on the homepage and browse the example binders, filtering by mini-binder, macrocycle or antibody. Each card shows the target and the measured affinity, so it doubles as a benchmark of expected output quality.
  2. 2Read a technical report
    Follow the arXiv links for Latent-X1, Latent-X2 or Latent-Y to understand the modeling approach and validation methodology before deciding whether the platform fits a program.
  3. 3Inspect a public demo output
    Open one of the linked demo design pages to see how a candidate binder is presented, including the structure view and the properties reported for that design.
  4. 4Request platform access
    Go to the tiers page and submit an access request. Expect to discuss intended targets and volume with the team, since pricing and quota are not published.
  5. 5Run a design against your target
    Once access is granted, launch a design run for your target of interest and review the returned candidate binders ranked by predicted binding and developability.

Pros and cons

Pros

  • Covers three binder formats (antibodies, macrocycles, mini-binders) in one platform rather than specializing in a single modalityAI
  • Publishes measured affinities for named targets, from picomolar antibodies down to micromolar binders, so the performance spread is visibleAI
  • Links peer-style technical reports for Latent-X1, Latent-X2 and Latent-Y, which supports real methodological due diligenceAI
  • Public demo output pages let a team inspect the result format before requesting accessAI
  • Framed around lab-validated designs and drug-like properties, which suits groups heading toward wet-lab workAI

Cons

  • Access is request-based through a tier page, so there is no self-serve signup, transparent quota or published per-design costAI
  • The site is labeled beta and the public material is thin on data handling, IP ownership and confidentiality termsAI
  • No documentation or API reference is exposed on the homepage, which makes pipeline integration hard to scope up frontAI
  • Validation claims are the company's own; buyers still need independent wet-lab confirmation before committing a programAI
  • Limited public detail on target classes, input formats and any restrictions on what can be submittedAI

How much does LatentLabs cost?

Pricing

Pricing is not published on the homepage. Access is handled through a tiers page with a request flow, and plans, quotas and per-design costs are only confirmed after contacting the company.

Learn more

Features

Generative design of antibodies, macrocycles and mini-proteins via the Latent-X models, with Latent-X1, Latent-X2 and Latent-Y each documented in a technical report. Outputs are presented on per-design pages with target and affinity data, and the homepage showcases experimentally validated binders with affinities from picomolar to micromolar.

Frequently asked questions about LatentLabs

  • How much does LatentLabs cost?
    Pricing is not published on the homepage. Access is handled through a tiers page with a request flow, and plans, quotas and per-design costs are only confirmed after contacting the company.
  • How do you use LatentLabs?
    The walkthrough on this page covers 5 steps: 1. Review the validated design gallery 2. Read a technical report 3. Inspect a public demo output 4. Request platform access 5. Run a design against your target.
  • What platforms does LatentLabs support?
    LatentLabs is available on Web App.
  • What are the limitations of LatentLabs?
    Access is request-based through a tier page, so there is no self-serve signup, transparent quota or published per-design cost. The site is labeled beta and the public material is thin on data handling, IP ownership and confidentiality terms. No documentation or API reference is exposed on the homepage, which makes pipeline integration hard to scope up front.

Status

StatusActive
Views0
Outbound clicks0
Added10/21/2026

Platforms

Web App

Pricing

PaidFree Trial